| Acute haemodynamic effects of the beta 1-adrenoceptor partial agonist xamoterol at rest and during supine exercise in patients with left ventricular dysfunction due to ischaemic heart disease: a double-blind randomized trial. | |
| | |
MedLine Citation:
|
PMID: 1971590 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The effects of xamoterol 0.2 mg kg-1 i.v. and placebo on left ventricular function at rest and on exercise were compared in patients with left ventricular dysfunction due to ischaemic heart disease. Improvements were seen in systolic and diastolic function at rest, and at up to 50% of maximal exercise, without evidence of worsening myocardial ischaemia. |
| | |
Authors:
|
P J de Feyter; P W Serruys |
Publication Detail:
|
Type: Clinical Trial; Journal Article; Randomized Controlled Trial |
Journal Detail:
|
Title: European heart journal Volume: 11 Suppl A ISSN: 0195-668X ISO Abbreviation: Eur. Heart J. Publication Date: 1990 Apr |
Date Detail:
|
Created Date: 1990-07-05 Completed Date: 1990-07-05 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 8006263 Medline TA: Eur Heart J Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 48-9 Citation Subset: IM |
Affiliation:
|
Thoraxcentre, Erasmus University, Rotterdam, The Netherlands. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adrenergic beta-Agonists
/
pharmacology Adult Aged Blood Pressure / drug effects* Cardiac Output / drug effects* Coronary Disease / physiopathology* Double-Blind Method Exercise / physiology* Humans Male Middle Aged Propanolamines / pharmacology* Randomized Controlled Trials as Topic Xamoterol |
| Chemical | |
Reg. No./Substance:
|
0/Adrenergic beta-Agonists; 0/Propanolamines; 81801-12-9/Xamoterol |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Echocardiographic assessment of lack of beta 1-receptor down-regulation during prolonged therapy wit...
Next Document: Comparative effects of xamoterol and digoxin in patients with mild to moderate heart failure. The It...